市場調査レポート

商品コード

1533630

分子診断の市場規模、シェア、成長分析：製品・サービス別、技術別、検査タイプ別、地域別 - 産業予測、2024年～2031年

Molecular Diagnostics Market Size, Share, Growth Analysis, By Product & Service (Reagents & Kits, Services & Software), By Technology (PCR, INAAT), By Test Type (Lab Tests PoC Tests), By Region - Industry Forecast 2024-2031

出版日: 2024年08月08日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の分子診断の市場規模は、2022年に140億米ドルとなり、2023年の156億米ドルから、2031年までには370億米ドルに成長し、予測期間（2024年～2031年）のCAGRは11.4％で成長する見通しです。

分子診断の世界市場は、技術の進歩、新しい診断ツールの市場開拓、感染症事例の増加、個別化医療の使用の増加などにより、大きな成長機会をもたらしています。分子診断は、遺伝子マーカー、タンパク質、その他の分析物など、疾患に関連する生体分子の検出と特性評価を行います。この分野は、感染症、腫瘍学、遺伝性疾患、薬理ゲノミクスなど、幅広い応用分野を包含しています。最近の技術進歩により、PCR、NGS、マイクロアレイなどの革新的技術が導入され、診断検査の感度と特異性が向上しました。これらの進歩は多重化能力を向上させ、より迅速で正確な疾患診断につながっています。市場は、特にHIV、肝炎、呼吸器感染症などの感染症罹患率の増加に伴い、大きく拡大しています。さらに、世界人口の高齢化、がんや遺伝性疾患のような慢性疾患の有病率の増加は、早期発見と標的治療のための効果的な分子診断ツールの必要性を浮き彫りにしています。分子診断の世界市場における主要企業には、Abbott Laboratories、F. Hoffmann-La Roche AG、Danaher Corporation、Qiagen N.V.、Thermo Fisher Scientific Inc.などがあります。これらの企業は、市場での存在感を強め、製品ラインナップを拡大するために、M&A、新製品の上市、戦略的提携などの成長戦略を積極的に推進しています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

F. Hoffmann-La Roche Ltd.（Switzerland）
Hologic, Inc.（US）
Abbott Laboratories（US）
Illumina, Inc.（US）
Thermo Fisher Scientific Inc.（US）
bioMerieux（France）
QIAGEN（Netherlands）
Agilent Technologies Inc.（US）
Becton Dickinson And Company（US）
Grifols S.A.（Spain）
Siemens AG（Siemens Healthineers）（Germany）
Bio-Rad Laboratories, Inc.（US）
Sysmex Corporation（Japan）
Quidel Corporation（US）
Biocartis（Belgium）
DiaSorin（Italy）
Myriad Genetics（US）
Revvity（US）
MDxHealth（Belgium）
OncoCyte Corporation（US）

Product Code: SQMIG35A2636

Global Molecular Diagnostics Market size was valued at USD 14.00 billion in 2022 and is poised to grow from USD 15.60 billion in 2023 to USD 37.00 billion by 2031, growing at a CAGR of 11.4% during the forecast period (2024-2031).

The global molecular diagnostics market presents substantial growth opportunities driven by advancements in technology, the development of new diagnostic tools, the rise in infectious disease cases, and the increasing use of personalized medicine. Molecular diagnostics involve detecting and characterizing disease-related biomolecules, such as genetic markers, proteins, and other analytes. This field encompasses a wide range of applications, including infectious diseases, oncology, genetic disorders, and pharmacogenomics. Recent technological progress has introduced innovations such as PCR, NGS, and microarrays, enhancing the sensitivity and specificity of diagnostic tests. These advancements have improved multiplexing capabilities, leading to quicker and more accurate disease diagnosis. The market is expanding significantly, particularly with the growing incidence of infectious diseases like HIV, hepatitis, and respiratory infections. Additionally, the aging global population and the increasing prevalence of chronic conditions such as cancer and genetic disorders highlight the need for effective molecular diagnostic tools for early detection and targeted treatment. Key players in the global molecular diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Qiagen N.V., and Thermo Fisher Scientific Inc. These companies are actively pursuing growth strategies such as mergers and acquisitions, new product launches, and strategic partnerships to strengthen their market presence and broaden their product offerings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Diagnostics Market Segmental Analysis

The global molecular diagnostics market is segmented by Product & Service, Test Type, Sample Type, Technology, Application, End User, and region. Based on Product & Service, the market is segmented into reagents & kits, instruments, and services & software. Based on Test Type, the market is segmented into Lab Tests, and PoC Tests. Based on Sample Type, the market is segmented into Blood, Serum, & Plasma, Urine, and Others. Based on Technology, the market is segmented into Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next- Generation Sequencing, In Situ Hybridization, DNA Microarrays, and Others. Based on Application, the market is segmented into Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, COVID-19, and Others. Based on Infectious Disease, the market is segmented into Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, and Other Infectious Diseases. Based on Oncology Testing, the market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Other Cancers. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Molecular Diagnostics Market

The rising incidence of infectious diseases such as HIV/AIDS, Hepatitis B and C, and Tuberculosis, alongside the increasing prevalence of genetic disorders, has amplified the demand for molecular diagnostics. Techniques like PCR and other molecular diagnostic methods enable precise and sensitive detection of pathogens. These technologies facilitate timely management and treatment of diseases and support the provision of personalized or individualized care.

Restraints in the Global Molecular Diagnostics Market

Despite their high accuracy and effectiveness, molecular diagnostic tests often come with substantial costs, making them inaccessible in many developing regions with limited healthcare budgets. The expense of molecular testing equipment, the necessary chemicals, and the skilled personnel required for these tests can place a significant financial burden on healthcare facilities. This high cost factor acts as a constraint on the growth of the molecular diagnostics market, particularly in less affluent areas.

Market Trends of the Global Molecular Diagnostics Market

The rise in point-of-care molecular testing is fueled by the demand for swift diagnosis and ongoing treatment monitoring across diverse healthcare environments, such as clinics, emergency rooms, and ambulances. The development of miniaturized and portable molecular diagnostic devices is making real-time testing feasible outside traditional laboratory settings, thereby improving patient care and increasing healthcare efficiency.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Technology Analysis
Regulatory Analysis
Patent Analysis
Value Chain Analysis
Trade Analysis
Case Study Analysis
Pricing Analysis
Supply Chain Analysis
PESTLE Analysis
Top Investment Pockets
Market Attractiveness Index
Market Ecosystem

Molecular Diagnostics Market by Product & Service

Market Overview
Reagents & Kits
Instruments
Services & Software

Molecular Diagnostics Market by Test Type

Market Overview
Lab Tests
PoC Tests

Molecular Diagnostics Market by Sample Type

Market Overview
Blood, Serum, and Plasma
Urine
Others

Molecular Diagnostics Market by Technology

Market Overview
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next- generation Sequencing
In Situ Hybridization
DNA Microarrays
Others

Molecular Diagnostics Market by Application

Market Overview
Infectious Disease Diagnostics
- Hepatitis
- HIV
- CT/NG
- HAI
- HPV
- Tuberculosis
- Influenza
- Other Infectious Diseases
Oncology Testing
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Other Cancers
Genetic Testing
COVID-19
Other Applications

Molecular Diagnostics Market by End User

Market Overview
Diagnostic Laboratories
Hospitals & Clinics
Other End Users

Molecular Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton Dickinson And Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens AG (Siemens Healthineers) (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocartis (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MDxHealth (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OncoCyte Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

分子診断の市場規模、シェア、成長分析：製品・サービス別、技術別、検査タイプ別、地域別 - 産業予測、2024年～2031年

Molecular Diagnostics Market Size, Share, Growth Analysis, By Product & Service (Reagents & Kits, Services & Software), By Technology (PCR, INAAT), By Test Type (Lab Tests PoC Tests), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

分子診断市場：製品・サービス別

分子診断市場：検査タイプ別

分子診断市場：サンプルタイプ別

分子診断市場：技術別

分子診断市場：用途別

分子診断市場：エンドユーザー別

分子診断市場規模：地域別